BEIGF Insider Transactions — Page 17
1,846 retained open-market purchase and sale rows from SEC Forms 3, 4 and 5, newest first. This page shows rows 1,601–1,700; provenance stays internal.
| Insider profile | Role | Date | Transaction | Shares | Price |
|---|---|---|---|---|---|
| Peterson Amy C. | CMO, Immuno-oncology | 2018-11-12 | Sale | 100.0 | $121.56 |
| Peterson Amy C. | CMO, Immuno-oncology | 2018-11-12 | Sale | 109.0 | $117.61 |
| Peterson Amy C. | CMO, Immuno-oncology | 2018-11-12 | Sale | 500.0 | $116.56 |
| Peterson Amy C. | CMO, Immuno-oncology | 2018-11-12 | Sale | 700.0 | $114.96 |
| Peterson Amy C. | CMO, Immuno-oncology | 2018-11-12 | Sale | 1,173.0 | $113.92 |
| Peterson Amy C. | CMO, Immuno-oncology | 2018-11-12 | Sale | 2,527.0 | $113.03 |
| Peterson Amy C. | CMO, Immuno-oncology | 2018-11-12 | Sale | 4,000.0 | $112.18 |
| Peterson Amy C. | CMO, Immuno-oncology | 2018-11-12 | Sale | 2,958.0 | $111.1 |
| Peterson Amy C. | CMO, Immuno-oncology | 2018-11-09 | Sale | 100.0 | $125.97 |
| Peterson Amy C. | CMO, Immuno-oncology | 2018-11-09 | Sale | 322.0 | $123.75 |
| Peterson Amy C. | CMO, Immuno-oncology | 2018-11-09 | Sale | 2,046.0 | $122.55 |
| Peterson Amy C. | CMO, Immuno-oncology | 2018-11-09 | Sale | 2,898.0 | $121.71 |
| Peterson Amy C. | CMO, Immuno-oncology | 2018-11-09 | Sale | 2,100.0 | $120.63 |
| Peterson Amy C. | CMO, Immuno-oncology | 2018-11-09 | Sale | 1,725.0 | $119.27 |
| Peterson Amy C. | CMO, Immuno-oncology | 2018-11-09 | Sale | 4,031.0 | $118.64 |
| Peterson Amy C. | CMO, Immuno-oncology | 2018-11-08 | Sale | 200.0 | $127.61 |
| Peterson Amy C. | CMO, Immuno-oncology | 2018-11-08 | Sale | 7,673.0 | $126.72 |
| Peterson Amy C. | CMO, Immuno-oncology | 2018-11-08 | Sale | 3,949.0 | $126.08 |
| Peterson Amy C. | CMO, Immuno-oncology | 2018-11-08 | Sale | 2,423.0 | $124.48 |
| Peterson Amy C. | CMO, Immuno-oncology | 2018-11-08 | Sale | 466.0 | $122.86 |
| Huang Jane | CMO, Hematology | 2018-09-04 | Sale | 2,911.0 | $174.6 |
| Glazer Donald W. | Director | 2018-08-30 | Sale | 1,000.0 | $179.0 |
| Glazer Donald W. | Director | 2018-08-29 | Sale | 1,000.0 | $179.0 |
| Peterson Amy C. | CMO, Immuno-oncology | 2018-08-23 | Sale | 961.0 | $170.46 |
| Peterson Amy C. | CMO, Immuno-oncology | 2018-08-23 | Sale | 1,400.0 | $169.75 |
| Peterson Amy C. | CMO, Immuno-oncology | 2018-08-23 | Sale | 2,300.0 | $168.94 |
| Peterson Amy C. | CMO, Immuno-oncology | 2018-08-23 | Sale | 1,108.0 | $167.54 |
| Wang Xiaodong | Director | 2018-08-13 | Sale | 549.0 | $164.11 |
| Wang Xiaodong | Director | 2018-08-13 | Sale | 700.0 | $159.21 |
| Wang Xiaodong | Director | 2018-08-13 | Sale | 2,200.0 | $157.29 |
| BAKER JULIAN | Director,TenPercentOwner | 2018-08-02 | Purchase | 5,231,900.0 | $108.0 |
| BAKER FELIX | Director,TenPercentOwner | 2018-08-02 | Purchase | 5,231,900.0 | $108.0 |
| BAKER BROS. ADVISORS LP | Director,TenPercentOwner | 2018-08-02 | Purchase | 5,231,900.0 | $108.0 |
| Baker Brothers Life Sciences LP | Director,TenPercentOwner | 2018-08-02 | Purchase | 5,231,900.0 | $108.0 |
| 667, L.P. | Director,TenPercentOwner | 2018-08-02 | Purchase | 5,231,900.0 | $108.0 |
| Baker Bros. Advisors (GP) LLC | Director,TenPercentOwner | 2018-08-02 | Purchase | 5,231,900.0 | $108.0 |
| BAKER JULIAN | Director,TenPercentOwner | 2018-08-02 | Purchase | 582,200.0 | $108.0 |
| BAKER FELIX | Director,TenPercentOwner | 2018-08-02 | Purchase | 582,200.0 | $108.0 |
| BAKER BROS. ADVISORS LP | Director,TenPercentOwner | 2018-08-02 | Purchase | 582,200.0 | $108.0 |
| Baker Brothers Life Sciences LP | Director,TenPercentOwner | 2018-08-02 | Purchase | 582,200.0 | $108.0 |
| 667, L.P. | Director,TenPercentOwner | 2018-08-02 | Purchase | 582,200.0 | $108.0 |
| Baker Bros. Advisors (GP) LLC | Director,TenPercentOwner | 2018-08-02 | Purchase | 582,200.0 | $108.0 |
| OYLER JOHN | Chief Executive Officer | 2018-07-16 | Sale | 2,550.0 | $164.12 |
| Liang Howard | CFO & Chief Strategy Officer | 2018-03-19 | Sale | 900.0 | $164.36 |
| Liang Howard | CFO & Chief Strategy Officer | 2018-03-19 | Sale | 4,636.0 | $163.48 |
| Liang Howard | CFO & Chief Strategy Officer | 2018-03-19 | Sale | 5,133.0 | $162.79 |
| Liang Howard | CFO & Chief Strategy Officer | 2018-03-19 | Sale | 3,141.0 | $161.62 |
| Liang Howard | CFO & Chief Strategy Officer | 2018-03-19 | Sale | 9,618.0 | $160.6 |
| Liang Howard | CFO & Chief Strategy Officer | 2018-03-19 | Sale | 5,200.0 | $159.62 |
| Liang Howard | CFO & Chief Strategy Officer | 2018-03-19 | Sale | 500.0 | $158.45 |
| Liang Howard | CFO & Chief Strategy Officer | 2018-03-16 | Sale | 400.0 | $157.98 |
| Liang Howard | CFO & Chief Strategy Officer | 2018-03-16 | Sale | 7,264.0 | $157.41 |
| Liang Howard | CFO & Chief Strategy Officer | 2018-03-16 | Sale | 2,208.0 | $156.75 |
| Liang Howard | CFO & Chief Strategy Officer | 2018-03-16 | Sale | 1,000.0 | $154.95 |
| OYLER JOHN | Chief Executive Officer | 2018-03-02 | Sale | 6,584.0 | $150.57 |
| OYLER JOHN | Chief Executive Officer | 2018-03-02 | Sale | 9,032.0 | $149.75 |
| OYLER JOHN | Chief Executive Officer | 2018-03-02 | Sale | 2,800.0 | $148.61 |
| OYLER JOHN | Chief Executive Officer | 2018-03-02 | Sale | 700.0 | $147.31 |
| OYLER JOHN | Chief Executive Officer | 2018-03-02 | Sale | 200.0 | $146.25 |
| OYLER JOHN | Chief Executive Officer | 2018-03-02 | Sale | 600.0 | $145.32 |
| OYLER JOHN | Chief Executive Officer | 2018-03-02 | Sale | 1,546.0 | $143.64 |
| OYLER JOHN | Chief Executive Officer | 2018-03-02 | Sale | 2,600.0 | $142.72 |
| OYLER JOHN | Chief Executive Officer | 2018-03-02 | Sale | 1,300.0 | $141.62 |
| OYLER JOHN | Chief Executive Officer | 2018-03-01 | Sale | 2,656.0 | $145.0 |
| OYLER JOHN | Chief Executive Officer | 2018-03-01 | Sale | 14,354.0 | $144.26 |
| OYLER JOHN | Chief Executive Officer | 2018-03-01 | Sale | 10,303.0 | $143.31 |
| OYLER JOHN | Chief Executive Officer | 2018-03-01 | Sale | 4,787.0 | $142.2 |
| OYLER JOHN | Chief Executive Officer | 2018-03-01 | Sale | 3,350.0 | $141.22 |
| OYLER JOHN | Chief Executive Officer | 2018-03-01 | Sale | 1,250.0 | $140.38 |
| OYLER JOHN | Chief Executive Officer | 2018-03-01 | Sale | 2,600.0 | $139.08 |
| OYLER JOHN | Chief Executive Officer | 2018-02-28 | Sale | 200.0 | $152.0 |
| OYLER JOHN | Chief Executive Officer | 2018-02-28 | Sale | 100.0 | $150.98 |
| OYLER JOHN | Chief Executive Officer | 2018-02-28 | Sale | 3,117.0 | $149.68 |
| OYLER JOHN | Chief Executive Officer | 2018-02-28 | Sale | 5,342.0 | $149.13 |
| OYLER JOHN | Chief Executive Officer | 2018-02-28 | Sale | 2,302.0 | $147.84 |
| OYLER JOHN | Chief Executive Officer | 2018-02-28 | Sale | 8,449.0 | $146.96 |
| OYLER JOHN | Chief Executive Officer | 2018-02-28 | Sale | 4,607.0 | $146.02 |
| OYLER JOHN | Chief Executive Officer | 2018-02-28 | Sale | 5,104.0 | $144.86 |
| OYLER JOHN | Chief Executive Officer | 2018-02-28 | Sale | 5,117.0 | $143.48 |
| Li Ji | EVP and Gl. Head of Bus. Dev. | 2018-02-28 | Sale | 2,400.0 | $149.49 |
| Li Ji | EVP and Gl. Head of Bus. Dev. | 2018-02-28 | Sale | 1,551.0 | $148.66 |
| Li Ji | EVP and Gl. Head of Bus. Dev. | 2018-02-28 | Sale | 1,800.0 | $146.92 |
| Li Ji | EVP and Gl. Head of Bus. Dev. | 2018-02-28 | Sale | 1,400.0 | $145.97 |
| Li Ji | EVP and Gl. Head of Bus. Dev. | 2018-02-28 | Sale | 1,100.0 | $144.78 |
| Li Ji | EVP and Gl. Head of Bus. Dev. | 2018-02-28 | Sale | 1,749.0 | $143.72 |
| BAKER JULIAN | Director,TenPercentOwner | 2018-01-18 | Purchase | 1,645,148.0 | $101.0 |
| BAKER FELIX | Director,TenPercentOwner | 2018-01-18 | Purchase | 1,645,148.0 | $101.0 |
| BAKER BROS. ADVISORS LP | Director,TenPercentOwner | 2018-01-18 | Purchase | 1,645,148.0 | $101.0 |
| Baker Brothers Life Sciences LP | Director,TenPercentOwner | 2018-01-18 | Purchase | 1,645,148.0 | $101.0 |
| 667, L.P. | Director,TenPercentOwner | 2018-01-18 | Purchase | 1,645,148.0 | $101.0 |
| Baker Bros. Advisors (GP) LLC | Director,TenPercentOwner | 2018-01-18 | Purchase | 1,645,148.0 | $101.0 |
| BAKER JULIAN | Director,TenPercentOwner | 2018-01-18 | Purchase | 335,050.0 | $101.0 |
| BAKER FELIX | Director,TenPercentOwner | 2018-01-18 | Purchase | 335,050.0 | $101.0 |
| BAKER BROS. ADVISORS LP | Director,TenPercentOwner | 2018-01-18 | Purchase | 335,050.0 | $101.0 |
| Baker Brothers Life Sciences LP | Director,TenPercentOwner | 2018-01-18 | Purchase | 335,050.0 | $101.0 |
| 667, L.P. | Director,TenPercentOwner | 2018-01-18 | Purchase | 335,050.0 | $101.0 |
| Baker Bros. Advisors (GP) LLC | Director,TenPercentOwner | 2018-01-18 | Purchase | 335,050.0 | $101.0 |
| OYLER JOHN | Chief Executive Officer | 2017-12-26 | Sale | 1,000.0 | $100.08 |
| OYLER JOHN | Chief Executive Officer | 2017-12-26 | Sale | 200.0 | $99.05 |
| OYLER JOHN | Chief Executive Officer | 2017-12-26 | Sale | 1,700.0 | $97.83 |